Varaico: Literature-Extracted Genetic Variants

Gene:SLC22A5
Variant:p.A44V
Back to variants list

SLC22A5

NM_003060.4:p.A44V

Associated Papers

Benefits and pitfalls in newborn screening for carnitine uptake deficiency: a 4-year single-center experience.

Turturo M et al.

Orphanet Journal of Rare Diseases, 2025

The global prevalence and genetic spectrum of primary carnitine deficiency.

Sun L et al.

Bmc Genomic Data, 2025

Conserved missense variant pathogenicity and correlated phenotypes across paralogous genes.

Brünger T et al.

Genome Biology, 2025

40624578 (PubMed )
Supplement: 13059_2025_3663_MOESM2_ESM.xlsx › SupplementaryTable1

A novel pathogenic variant in the carnitine transporter gene, SLC22A5, in association with metabolic carnitine deficiency and cardiomyopathy features.

Jolfayi AG et al.

Bmc Cardiovascular Disorders, 2024

Primary carnitine deficiency: Estimation of prevalence in Chinese population and insights into newborn screening.

Ji X et al.

Frontiers in Genetics, 2023

38125748 (PubMed )
Supplement: Table1.XLSX › TableS1

Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter Deficiency.

Koleske ML et al.

Proceedings of the National Academy of Sciences of the United States of America, 2022

36343260 (PubMed )
Supplement: pnas.2210247119.sd01.xlsx › Dataset_S2

Carnitine levels and mutations in the SLC22A5 gene in Faroes patients with Parkinson's disease.

Crooks SA et al.

Neuroscience Letters, 2018

Functional and molecular studies in primary carnitine deficiency.

Frigeni M et al.

Human Mutation, 2017

Biochemical characteristics of newborns with carnitine transporter defect identified by newborn screening in California.

Gallant NM et al.

Molecular Genetics and Metabolism, 2017

Carnitine transport and fatty acid oxidation.

Longo N et al.

Biochimica Et Biophysica Acta, 2016

Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands.

Rasmussen J et al.

Journal of Inherited Metabolic Disease, 2014

Residual OCTN2 transporter activity, carnitine levels and symptoms correlate in patients with primary carnitine deficiency.

Rasmussen J et al.

Molecular Genetics and Metabolism Reports, 2014

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."